These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 16164632)

  • 41. Podocyte injury and overexpression of vascular endothelial growth factor and transforming growth factor-beta 1 in adriamycin-induced nephropathy in rats.
    Yang W; Wang J; Shi L; Yu L; Qian Y; Liu Y; Wang W; Cheng S
    Cytokine; 2012 Aug; 59(2):370-6. PubMed ID: 22579701
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Podocyte vascular endothelial growth factor (Vegf₁₆₄) overexpression causes severe nodular glomerulosclerosis in a mouse model of type 1 diabetes.
    Veron D; Bertuccio CA; Marlier A; Reidy K; Garcia AM; Jimenez J; Velazquez H; Kashgarian M; Moeckel GW; Tufro A
    Diabetologia; 2011 May; 54(5):1227-41. PubMed ID: 21318407
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interference with TGF-beta signaling by Smad3-knockout in mice limits diabetic glomerulosclerosis without affecting albuminuria.
    Wang A; Ziyadeh FN; Lee EY; Pyagay PE; Sung SH; Sheardown SA; Laping NJ; Chen S
    Am J Physiol Renal Physiol; 2007 Nov; 293(5):F1657-65. PubMed ID: 17804483
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Amelioration of long-term renal changes in obese type 2 diabetic mice by a neutralizing vascular endothelial growth factor antibody.
    Flyvbjerg A; Dagnaes-Hansen F; De Vriese AS; Schrijvers BF; Tilton RG; Rasch R
    Diabetes; 2002 Oct; 51(10):3090-4. PubMed ID: 12351452
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Increased urinary type IV collagen marks the development of glomerular pathology in diabetic d/db mice.
    Cohen MP; Lautenslager GT; Shearman CW
    Metabolism; 2001 Dec; 50(12):1435-40. PubMed ID: 11735089
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sulodexide ameliorates early but not late kidney disease in models of radiation nephropathy and diabetic nephropathy.
    Rossini M; Naito T; Yang H; Freeman M; Donnert E; Ma LJ; Dunn SR; Sharma K; Fogo AB
    Nephrol Dial Transplant; 2010 Jun; 25(6):1803-10. PubMed ID: 20061322
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Low TGFβ1 expression prevents and high expression exacerbates diabetic nephropathy in mice.
    Hathaway CK; Gasim AM; Grant R; Chang AS; Kim HS; Madden VJ; Bagnell CR; Jennette JC; Smithies O; Kakoki M
    Proc Natl Acad Sci U S A; 2015 May; 112(18):5815-20. PubMed ID: 25902541
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Empagliflozin alleviates podocytopathy and enhances glomerular nephrin expression in
    Klimontov VV; Korbut AI; Taskaeva IS; Bgatova NP; Dashkin MV; Orlov NB; Khotskina AS; Zavyalov EL; Klein T
    World J Diabetes; 2020 Dec; 11(12):596-610. PubMed ID: 33384767
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Glycated albumin promotes a generalized vasculopathy in the db/db mouse.
    Cohen MP; Clements RS; Cohen JA; Shearman CW
    Biochem Biophys Res Commun; 1996 Jan; 218(1):72-5. PubMed ID: 8573179
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects on protein kinase C-beta inhibition on glomerular vascular endothelial growth factor expression and endothelial cells in advanced experimental diabetic nephropathy.
    Kelly DJ; Buck D; Cox AJ; Zhang Y; Gilbert RE
    Am J Physiol Renal Physiol; 2007 Aug; 293(2):F565-74. PubMed ID: 17522264
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 2-(8-hydroxy-6-methoxy-1-oxo-1h-2-benzopyran-3-yl) propionic acid, an inhibitor of angiogenesis, ameliorates renal alterations in obese type 2 diabetic mice.
    Ichinose K; Maeshima Y; Yamamoto Y; Kinomura M; Hirokoshi K; Kitayama H; Takazawa Y; Sugiyama H; Yamasaki Y; Agata N; Makino H
    Diabetes; 2006 May; 55(5):1232-42. PubMed ID: 16644677
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Glycated albumin increases oxidative stress, activates NF-kappa B and extracellular signal-regulated kinase (ERK), and stimulates ERK-dependent transforming growth factor-beta 1 production in macrophage RAW cells.
    Cohen MP; Shea E; Chen S; Shearman CW
    J Lab Clin Med; 2003 Apr; 141(4):242-9. PubMed ID: 12677169
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cellular and molecular mechanisms of proteinuria in diabetic nephropathy.
    Wolf G; Ziyadeh FN
    Nephron Physiol; 2007; 106(2):p26-31. PubMed ID: 17570945
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Chronic hypoxia exacerbates diabetic glomerulosclerosis through mesangiolysis and podocyte injury in db/db mice.
    Takahashi N; Yoshida H; Kimura H; Kamiyama K; Kurose T; Sugimoto H; Imura T; Yokoi S; Mikami D; Kasuno K; Kurosawa H; Hirayama Y; Naiki H; Hara M; Iwano M
    Nephrol Dial Transplant; 2020 Oct; 35(10):1678-1688. PubMed ID: 32596728
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Renal handling of glycated albumin in non-insulin-dependent diabetes mellitus with nephropathy.
    Cha T; Tahara Y; Yamato E; Yoneda H; Ikegami H; Noma Y; Shima K; Ogihara T
    Diabetes Res Clin Pract; 1991 Jul; 12(3):149-56. PubMed ID: 1889345
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Xanthine oxidoreductase inhibitor topiroxostat ameliorates podocyte injury by inhibiting the reduction of nephrin and podoplanin.
    Zhang Y; Fukusumi Y; Kayaba M; Nakamura T; Sakamoto R; Ashizawa N; Kawachi H
    Nefrologia (Engl Ed); 2021; 41(5):539-547. PubMed ID: 36165136
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Early Enhanced Leucine-Rich
    Haku S; Wakui H; Azushima K; Haruhara K; Kinguchi S; Ohki K; Uneda K; Kobayashi R; Matsuda M; Yamaji T; Yamada T; Minegishi S; Ishigami T; Yamashita A; Ohashi K; Tamura K
    Biomed Res Int; 2018; 2018():2817045. PubMed ID: 30515388
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Critical role for osteopontin in diabetic nephropathy.
    Nicholas SB; Liu J; Kim J; Ren Y; Collins AR; Nguyen L; Hsueh WA
    Kidney Int; 2010 Apr; 77(7):588-600. PubMed ID: 20130530
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Glomerular barrier dysfunction in glomerulosclerosis- resistant Milan rats with experimental diabetes: the role of renal haemodynamics.
    Pugliese G; Ricci C; Iacobini C; Menini S; Fioretto P; Ferrandi M; Giardino LA; Armelloni S; Mattinzoli D; Rastaldi MP; Pugliese F
    J Pathol; 2007 Oct; 213(2):210-8. PubMed ID: 17768702
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The renal TGF-beta system in the db/db mouse model of diabetic nephropathy.
    Cohen MP; Sharma K; Guo J; Eltayeb BO; Ziyadeh FN
    Exp Nephrol; 1998; 6(3):226-33. PubMed ID: 9639038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.